Predict your next investment


See what CB Insights has to offer

Founded Year



Other Investors | Alive

About Veraxa Health

The Joslin Vision NetworkTM (JVN) is a technology and clinical service designed to prevent blindness and vision loss for people with diabetes. Using Joslin's imaging system, patients can be evaluated for diabetic eye disease by Joslin clinicians, conveniently, pain-free and without the risks or recovery time of traditional pupil dilation. This means that an eye health exam, which may have been previously difficult for or even unavailable to many, is now fast, simple and readily available. Using the JVN in a primary care environment increases diabetic retinopathy surveillance and efficient use of specialty care. This translates to better care and health outcomes for patients and greater clinical excellence, cost-effectiveness and practice efficiency for physicians.

Veraxa Health Headquarter Location

20 Overland Street 4th Floor

Boston, Massachusetts, 02215,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Veraxa Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Veraxa Health is included in 1 Expert Collection, including Diabetes.



1,750 items

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.